RIGEL PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $117.2M
Liabilities Breakdown FY2023
Total Liabilities: $145.9M
Asset Breakdown
Total Assets: $117.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $32.8M | 28.0% |
| Accounts Receivable | $30.6M | 26.1% |
| Inventory | $5.5M | 4.7% |
| Property, Plant & Equipment | $165.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $13.9M | 11.8% |
| Other Assets | $34.3M | 29.3% |
Liabilities Breakdown
Total Liabilities: $145.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.1M | 4.9% |
| Long-Term Debt | $60.0M | 41.1% |
| Other Liabilities | $78.7M | 54.0% |